1.45
Neuronetics Inc stock is traded at $1.45, with a volume of 1.39M.
It is up +14.17% in the last 24 hours and up +8.21% over the past month.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
See More
Previous Close:
$1.27
Open:
$1.33
24h Volume:
1.39M
Relative Volume:
0.71
Market Cap:
$100.45M
Revenue:
$149.16M
Net Income/Loss:
$-39.14M
P/E Ratio:
-2.4264
EPS:
-0.5976
Net Cash Flow:
$-21.18M
1W Performance:
-0.34%
1M Performance:
+8.21%
6M Performance:
-46.89%
1Y Performance:
-60.60%
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
STIM
Neuronetics Inc
|
1.45 | 87.98M | 149.16M | -39.14M | -21.18M | -0.5976 |
|
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
Neuronetics to report fourth quarter 2025 results March 17 - MSN
Chernett buys Neuronetics (STIM) shares worth $481,802 By Investing.com - Investing.com India
Chernett buys Neuronetics (STIM) shares worth $481,802 - Investing.com
Ten percent owner Jorey Chernett boosts Neuronetics (STIM) stake with 385K-share buy - Stock Titan
Insider Buying: Jorey Chernett Acquires 500,000 Shares of Neuron - gurufocus.com
Neuronetics Insider Bought Shares Worth $675,000, According to a Recent SEC Filing - marketscreener.com
Chernett Jorey buys Neuronetics (STIM) shares worth $675,000 - Investing.com
Neuronetics 10% Owner Purchased Shares Worth Over $675K - TradingView
[Form 4] Neuronetics, Inc. Insider Trading Activity - Stock Titan
Aug Rallies: Does Neuronetics Inc have a competitive edge2026 Valuation Update & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Neuronetics appoints Dan Reuvers as CEO, succeeding Keith Sullivan - MSN
Neuronetics (STIM) price target decreased by 53.85% to 3.06 - MSN
Insider Buying: Jorey Chernett Acquires 150,000 Shares of Neuron - gurufocus.com
Chernett Jorey buys Neuronetics (STIM) shares worth $211,000 - Investing.com
Chernett Jorey buys Neuronetics (STIM) shares worth $211,000 By Investing.com - in.investing.com
Neuronetics (STIM) 10% owner Jorey Chernett buys 150,000 shares - Stock Titan
Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook - MyChesCo
Neuronetics (NASDAQ:STIM) Director Sells $62,027.26 in Stock - MarketBeat
Neuronetics (NASDAQ:STIM) EVP Sells $21,446.70 in Stock - MarketBeat
Published on: 2026-03-25 12:08:27 - baoquankhu1.vn
Top Neuronetics Insiders Quietly Unload a Wave of Shares in Rapid-Fire Moves - TipRanks
Neuronetics EVP Macan sells $21k in shares By Investing.com - Investing.com South Africa
Neuronetics: former officer Sullivan sells $62k in shares By Investing.com - Investing.com South Africa
Neuronetics EVP Pfanstiel sells $22k in shares By Investing.com - Investing.com Australia
Neuronetics EVP Pfanstiel sells $22k in shares - Investing.com
Neuronetics: former officer Sullivan sells $62k in shares - Investing.com
Neuronetics EVP Macan sells $21k in shares - Investing.com
Neuronetics (STIM) CFO Pfanstiel sells 16,431 shares to cover tax withholding - Stock Titan
Neuronetics (STIM) ex-officer sells 46,289 shares to cover tax withholding - Stock Titan
Neuronetics (STIM) EVP Macan sells 16,005 shares to cover RSU tax - Stock Titan
Neuronetics Appoints Dan Reuvers as CEO, Succeeding Keith Sullivan - MyChesCo
Layoff Watch: Does Neuronetics Inc have pricing power2026 Technical Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Neuronetics (STIM) CEO awarded 1,500,000 restricted stock units in equity grant - Stock Titan
Neuronetics (STIM) CEO Daniel Reuvers named as insider in Form 3 - Stock Titan
Insider Buying: Jorey Chernett Acquires Additional Shares of Neu - gurufocus.com
Insider Buying: Neuronetics (NASDAQ:STIM) Major Shareholder Buys $238,955.52 in Stock - MarketBeat
Chernett Jorey buys Neuronetics (STIM) shares worth $238,955 By Investing.com - Investing.com Australia
Chernett Jorey buys Neuronetics (STIM) shares worth $238,955 - Investing.com
Major Neuronetics (NASDAQ: STIM) holder adds 169K shares - Stock Titan
Neuronetics: Highly Speculative, But Revenue Growth Could Drive The Stock Higher (STIM) - Seeking Alpha
Malvern’s Neuronetics Announces New CEO as 2025 Revenue Nearly Doubles to $149M - BUCKSCO.Today
Neuronetics (NASDAQ:STIM) Stock Rating Lowered by Wall Street Zen - MarketBeat
Major Investor Makes Bold Move Into Neuronetics Stock - TipRanks
Form 144 Neuronetics For: 19 March By Investing.com - Investing.com Australia
Insider Buying: Neuronetics (NASDAQ:STIM) Major Shareholder Acquires $819,990.00 in Stock - MarketBeat
Jorey Chernett Buys 450,000 Shares of Neuronetics (NASDAQ:STIM) Stock - MarketBeat
Insider Buying: Jorey Chernett Acquires 1,057,400 Shares of Neur - gurufocus.com
Chernett Jorey buys Neuronetics (STIM) shares worth $1.42 million - Investing.com UK
Neuronetics 10% Owner Purchased Shares Worth Over $1.4M - TradingView
Chernett Jorey buys Neuronetics (STIM) shares worth $1.42 million By Investing.com - Investing.com Australia
Neuronetics Insider Bought Shares Worth $1,418,490, According to a Recent SEC Filing - marketscreener.com
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neuronetics Inc Stock (STIM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chernett Jorey | 10% Owner |
Mar 27 '26 |
Buy |
1.35 |
500,000 |
675,000 |
9,393,276 |
| Chernett Jorey | 10% Owner |
Mar 25 '26 |
Buy |
1.40 |
125,000 |
175,000 |
8,868,276 |
| Chernett Jorey | 10% Owner |
Mar 26 '26 |
Buy |
1.44 |
25,000 |
36,000 |
8,893,276 |
| Pfanstiel Steven | EVP, CFO and Treasurer |
Mar 19 '26 |
Sale |
1.34 |
16,431 |
22,018 |
828,781 |
| Sullivan Keith J | Former Officer & Director |
Mar 19 '26 |
Sale |
1.34 |
46,289 |
62,027 |
1,590,924 |
| MACAN WILLIAM ANDREW | EVP, CLO and CS |
Mar 19 '26 |
Sale |
1.34 |
16,005 |
21,447 |
897,270 |
| Chernett Jorey | 10% Owner |
Mar 20 '26 |
Buy |
1.41 |
169,472 |
238,956 |
8,743,276 |
| Chernett Jorey | 10% Owner |
Mar 18 '26 |
Buy |
1.35 |
607,400 |
819,990 |
8,123,804 |
| Chernett Jorey | 10% Owner |
Mar 19 '26 |
Buy |
1.33 |
450,000 |
598,500 |
8,573,804 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):